Fertility doc backs off on custom kids
By United Press International,
United Press International
| 03. 04. 2009
A New York fertility doctor says he will be limiting his genetics work to dodging diseases rather than customizing physical traits such as hair and eye color.
Dr. Jeff Steinberg caused a stir this week with claims that he could help parents predetermine various characteristics of future offspring but the New York Daily News said Wednesday he is holding off for the time being.
"We are going to limit it to people with genetic diseases because we just cannot keep up with what's going on," Steinberg said.
Steinberg's clinics in New York and Los Angeles will be focusing on such disorders as color blindness and albinism, the newspaper said.
The Daily News said word of Steinberg's ability to select embryos with desirable physical traits and gender appalled some New York parents while others thought it was a great idea.
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...
